First-line Remicade effective in children with Crohn’s

First-line Remicade therapy was superior to conventional treatment in achieving short-term remission in children with Crohn’s disease, according to study results.Lissy de Ridder, MD, PhD, from the gastroenterology department at Erasmus MC Sophia Children Hospital in the Netherlands, and colleagues wrote that Remicade (infliximab, Janssen) is usually only started in children with CD if conventional treatments are ineffective.“In many pediatric patients with CD, however, particularly in those with moderate- to- severe CD, mucosal healing and sustained clinical remission are notRead More

Share on facebook
Share on twitter
Share on linkedin